Cas 1125671-07-9,3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one

1125671-07-9

Post Buying Request

Basic information

Product Name: 3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one
Synonyms: 3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one
CAS NO:1125671-07-9
Molecular Formula:
Molecular Weight: 380.441
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one(CAS DataBase Reference)
NIST Chemistry Reference: 3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one(1125671-07-9)
EPA Substance Registry System: 3-(4-methoxy-3,5-dimethylphenyl)-7-(tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one(1125671-07-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1125671-07-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1125671-07-9 Suppliers

Recommended suppliers

1125671-07-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1125671-07-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,5,6,7 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1125671-07:
(9*1)+(8*1)+(7*2)+(6*5)+(5*6)+(4*7)+(3*1)+(2*0)+(1*7)=129
129 % 10 = 9
So 1125671-07-9 is a valid CAS Registry Number.

1125671-07-9Upstream product

1125671-07-9Downstream Products

1125671-38-6 C₁₈H₁₆O₄

1125671-07-9Relevant academic research and scientific papers

FLAVONOID PPAR AGONISTS

-

Page/Page column 36; 62, (2009/04/25)

The present invention relates to PPAR agonists, and their use in therapy including the treatment of disease. In particular, the invention relates to flavonoid compounds which are PPAR-gamma agonists and/or PPAR alpha/gamma dual agonists.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1125671-07-9